Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers April 28, 2017
Pharmacy Choice - News - Over-the-Counter Drugs - April 28, 2017

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 100     Next >>     Go To Page:

4/20/17 - BioPharmX Completes Last Subject Visit in its Phase 2b Trial of BPX-01, Expects to Report Topline Results First Half of May 2017
BioPharmX Corporation, a specialty pharmaceutical company developing products for the dermatology market, announced the last subject visit in its Phase 2 b trial was on March 24, 2017 and the last investigational site close-out visit was April 7, 2017. BioPharmX Corporation is a Silicon Valley- based specialty pharmaceutical company that seeks to
4/20/17 - FDA further restricts pain medication use in kids
The FDA also said breastfeeding women shouldn't take them because of possible harm to the baby. The FDA urged parents to carefully read labels of nonprescription cough medicines to avoid codeine and to consult a doctor or pharmacist if needed. On Thursday, FDA said that some children are at higher risk of harm from the medicines because they break
4/20/17 - FDA statement from Douglas Throckmorton, M.D., deputy center director for regulatory programs, Center for Drug Evaluation and Research, on new...
FDA statement from Douglas Throckmorton, M.D., deputy center director for regulatory programs, Center for Drug Evaluation and Research, on new warnings about the use of codeine and tramadol in children& nursing mothers. The health and safety of children is a top priority at the FDA, which is why today we are requiring a series of changes to the lab
4/20/17 - HEALTH & SUPPORT
Tuesday nights at The Boston Center for Addiction Medicine, 75 Lindell St., Danvers. Held 7-8: 30 p.m. on the last Wednesday of each month in the doctors conference room at Beverly Hospital, 85 Herrick St., Beverly. Financial counselors are available at Beverly Hospital, 85 Herrick St., Beverly, to assist you in accessing health insurance.
4/20/17 - NEUROMETRIX, INC. - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations
Unless the context otherwise requires, all references to "we", "us", the "Company", or "NeuroMetrix" in this Quarterly Report on Form 10- Q refer to NeuroMetrix, Inc.. NeuroMetrix is a commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, slee
4/20/17 - Piramal Enterprises Partners with Indian Pharmaceutical Association to Educate Stakeholders on Responsible Self-Care [India Infoline News Service]
Piramal Enterprises Partners with Indian Pharmaceutical Association to Educate Stakeholders on Responsible Self-Care Business Wire India Piramal Enterprises Consumer Products business has partnered with the Indian Pharmaceutical Association, to promote responsible self-care to over 5,000 chemists in India, starting in the Eastern region.
4/20/17 - Support for Over-the-Counter Hearing Aids Grows
Washington, D.C.- In a signal of growing support for the bipartisan Over-the-Counter Hearing Aid Act of 2017, Consumers Union, the National Committee to Preserve Social Security& Medicare, and the Academy of Doctors of Audiology have released letters endorsing the legislation. The National Committee to Preserve Social Security and Medicare noted th
4/20/17 - Support for Over-the-Counter Hearing Aids Grows Among Consumer Advocates and Hearing Health Professionals
Washington, D.C. In a signal of growing support for the bipartisan Over-the-Counter Hearing Aid Act of 2017, Consumers Union, the National Committee to Preserve Social Security& Medicare, and the Academy of Doctors of Audiology have released letters endorsing the legislation. The National Committee to Preserve Social Security and Medicare noted t
4/20/17 - Trumping Healthcare's Bad Hand OpEd [Eurasia Review]
Congressional Republicans have only themselves to blame. Since returning to majority in the House in January 2011, Republicans have formally voted 54 times to address all or part of Obamacare. It simply stated: such Act is repealed, and the provisions of law amended or repealed by such Act are restored or revived as if such Act had not been enac
4/20/17 - VANC Pharmaceuticals Appointment of Mr. Alan Arnstein to its Board of Directors
VANC Pharmaceuticals Inc., a pharmaceutical company focused on the Canadian generic drug and over-the-counter markets is pleased to announce the appointment of Mr. Mr. Arnstein previously worked for the Katz Group Canada where he oversaw the development of the Medicine Shoppe from 28 stores to 175 stores before the successful sale to McKesson Canad
4/19/17 - Boehringer Ingelheim Phase III Study Now Enrolling Patients with Progressive Fibrosing Lung Diseases
Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the first patient has been enrolled in the PF-ILD trial. This study investigates the efficacy and safety of nintedanib in a range of progressive fibrosing lung conditions other than idiopathic pulmonary fibrosis. "This trial enrolls patients who have lung fibrosis of at least 10 per
4/19/17 - Cosmos Holdings, Inc. Announces Full-Year 2016 Results
Cosmos Holdings, Inc., an international pharmaceutical company, announced financial results for the year ended December 31, 2016. For the year ended December 31, 2016, versus the year ended December 31, 2015, Cosmos Holdings' revenue improved 1,166 percent to $6.8 million from $0.5 million on the strength of its SkyPharm SA subsidiary, which obtain
4/19/17 - Credence Research: Global In-Vitro Diagnostics Market To Reach Worth USD 81.35 Bn By 2022 : Credence Research
According to the latest report published by Credence Research, Inc. "Global In-vitro Diagnostics Market- Growth, Opportunities, Competitive Analysis, and Forecast, 2016- 2022," the in-vitro diagnostics market was valued at USD 60,468.7 Mn in 2015, and is expected to reach USD 81,345.1 Mn by 2022, expanding at a CAGR of 4.2% from 2016 to 2022..
4/19/17 - FTC Workshop Looks at Hearing Aids and OTC Hearing Devices
The FTC held the workshop, Now Hear This looking at a myriad of issues surrounding technology and competition in hearing healthcare, as well as how over-the-counter hearing aids might impact customer satisfaction, the use of amplification products, consumer safety, and professional care.
4/19/17 - Ipsen Biopharmaceuticals, Inc. Announces Five Poster Presentations of Dysport (abobotulinumtoxinA) Data at the 2017 Annual Meeting of the American Academy of Neurology
Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen, today announced that five abstracts regarding Dysport data have been accepted for poster presentations at the annual meeting of the American Academy of Neurology on April 22-28, 2017 in Boston, MA.. Two abstracts specifically look at data about the time to retreatment with Dysport an i
4/19/17 - Johnson & Johnson Posts Sluggish Sales, Boosts Guidance on Actelion Deal [Sport360]
The healthcare industry is in constant flux, but Johnson& Johnson aims to be a blue-chip stalwart for investors in the space to get wide-ranging exposure throughout the sector. With reform efforts ongoing and criticism of high-priced drugs from pharmaceutical manufacturers, J&J has had to navigate a difficult industry environment lately, but coming
4/19/17 - Over-the-Counter Drugs Market Trends and Growth Propellers 2024
Albany, NY 04/19/2017 Over-the-counter drugs, also known as non-prescription drugs, refer to medicines that can be bought without a prescription. These drugs are safe and effective when a consumer follows the directions on the label or as provided by a physician. Hence, some of these drugs have restrictions in the U.S. This restricted class o
4/18/17 - Advil, Motrin and other NSAIDs painkillers should be prescription only, Danish study says [Pittsburgh Post-Gazette]
April 18 Over-the-counter painkillers known as nonsteroidal anti-inflammatory drugs under the well-known brand names of Advil, Motrin and Aleve, to name a few are among the most commonly used drugs on the planet as temporary treatment for headaches, arthritis, gout, muscle aches, athletic injuries and other discomforts. That's why a recent Da
4/18/17 - Egalet Announces U.S. Food and Drug Administration Acceptance of File for Prior Approval Supplement for OXAYDO (oxycodone HCl, USP) tablets C-II 10 mg and 15 mg Dosage Strengths
Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions, today announced that the submission of a prior approval supplement for OXAYDO tablets C-II, seeking approval of 10 mg and 15 mg dosage strengths, has been accepted for f
4/18/17 - Overcoming opioids Overcoming Opioids: The quest for less addictive drugs Drug companies race to find less-addictive alternatives to stem epidemic
Doctors carve from hip to hip, slicing off skin, tightening muscles, tugging at innards. Patients often need strong painkillers for days or even weeks, but Mary Hernandez went home on just over-the-counter ibuprofen. The Houston woman was helping test a novel medicine aimed at avoiding opioids, potent pain relievers fueling an epidemic of overuse a
4/18/17 - PROVECTUS BIOPHARMACEUTICALS, INC. (OTCMKTS:PVCT) Files An 8-K Other Events
PROVECTUS BIOPHARMACEUTICALS, INC. (OTCMKTS:PVCT) Files An 8-K Other Events Item8.01. Other Events. The recently reconstituted Compensation Committee, comprised of Bruce Horowitz, Dominic Rodrigues and Jan Koe (the Compensation Committee), of the Board of Directors (the Board) of Provectus Biopharmaceuticals, Inc. (the Company) met on April12, 2017
4/18/17 - Santalis Pharmaceuticals Announces Issuance of an Australian Patent Covering the Use of Sandalwood Oil to Treat Cancers
Santalis Pharmaceuticals, Inc. announced today the granting by the Australian Patent Office of patent No. 2011223758 containing sixteen claims covering the use of sandalwood oil compositions to treat a variety of cancers including leukemia and solid tumors, such as bladder cancer, and others. Paul Castella, CEO of Santalis Pharmaceuticals, We
4/18/17 - Upcoming Event: Leading Associations Representing the Dietary Supplement Industry Hosting Inaugural Event
The seminar represents an unprecedented collaboration by the Consumer Healthcare Products Association, the Council for Responsible Nutrition, the American Herbal Products Association, and the United Natural Products Alliance aimed at convening stakeholders from across the dietary supplement sector to discuss issues, trends, and opportunities for...
4/18/17 - Veterinarian: Several over-the-counter pet antibiotics available [Bluefield Daily Telegraph, W.Va.]
April 18 PRINCETON Most over-the-counter antibiotics are injectable products labeled for a specific use in large animals according to local veterinarian William Streit. Several over-the-counter antibiotics are available in West Virginia for treating pets according to Streit. Veterinarian Katie Hughes said she is not aware of illegal drugs being
4/17/17 - CreakyJoints Advocates for Transparent Drug Pricing by Insurance Companies
CreakyJoints today announces a new policy platform that advocates for transparent drug pricing by encouraging stakeholders, such as the U.S. Food and Drug Administration, pharmaceutical companies, health insurance companies and pharmacy benefit managers, to better communicate about pricing practices and take steps to pass along discounts and pri
Articles(s): 1 - 25 of 100     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415